Related Experiment Video
Updated: Jan 3, 2026

28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
12.7K
Standardized Pathology Report for Colorectal Cancer, 2nd Edition
Baek-Hui Kim1, Joon Mee Kim2, Gyeong Hoon Kang3
1Department of Pathology, Korea University Guro Hospital, Seoul, Korea.
Journal of Pathology and Translational Medicine
|November 14, 2019
Summary
The updated Standardized Pathology Report for Colorectal Cancer (CRC) provides Korean pathologists with essential guidelines for diagnosis and treatment. This revised report incorporates recent advancements in pathology, ensuring better patient care.
Area of Science:
- Pathology
- Oncology
Background:
- The initial Standardized Pathology Report for Colorectal Cancer (CRC) was published 13 years ago.
- Significant advancements in CRC diagnosis, pathology reporting, and molecular/immunohistochemical techniques necessitate an update.
Purpose of the Study:
- To revise and update the standardized pathology report for colorectal cancer.
- To provide Korean pathologists with a practical protocol for CRC diagnosis and treatment.
Main Methods:
- Development of a revised standardized pathology report by the Gastrointestinal Pathology Study Group (GIP) of the Korean Society of Pathologists.
- Categorization of report elements into "standard data elements" (basic findings, prognostication) and "conditional data elements" (adjuvant therapy factors).
- Inclusion of a Korean version for enhanced usability.
Main Results:
- The second edition of the report reflects current changes in CRC pathology.
- The report is structured with standard and conditional data elements to accommodate institutional needs.
- A Korean version is available to facilitate understanding and application.
Conclusions:
- The updated report aims to improve the daily practice of CRC diagnosis and treatment for Korean pathologists.
- This standardized protocol will aid in accurate prognostication and treatment decisions for colorectal cancer patients.

